Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion description "[RyR2 cardiac Ca(2+) release channel inhibition appears to determine efficacy of class I drugs for the prevention of CPVT in Casq2(-/-) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion evidence source_evidence_literature NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion SIO_000772 21270101 NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion wasDerivedFrom befree-20150227 NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_assertion wasGeneratedBy ECO_0000203 NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP282632.RAaZqF5qmzytxAH0BECcx-Xz6cwNkj5IwCLQAWS8F4dEw130_provenance.